GlassScriptPhysician profile
Wyatt A Schmidt
NPI 1215281282
$1,185.43
in general payments reported to CMS, 2019-2025
20 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2022: $162 · 2023: $131 · 2024: $199 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $207.14 | 2021-2025 | Farxiga |
| Lilly USA, LLC | $139.98 | 2021-2025 | Mounjaro |
| Abbvie INC. | $118.88 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.73 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $101.30 | 2021-2025 | Spravato, Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $81.52 | 2021-2025 | Trintellix |
| Philips North America LLC | $68.55 | 2024 | (Ck7) Extended Holter |
| Novo Nordisk INC | $59.26 | 2021-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $56.49 | 2021-2022 | |
| Horizon Therapeutics Plc | $53.59 | 2021 | |
| Azurity Pharmaceuticals, INC. | $38.20 | 2023-2024 | Edarbi, Edarbi |
| Mylan Specialty L.P. | $26.10 | 2021-2023 | Yupelri |
| Pfizer INC. | $25.30 | 2021 | |
| Scpharmaceuticals INC. | $23.35 | 2025 | |
| Astellas Pharma US INC | $17.60 | 2025 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $15.65 | 2025 | Nuzyra |
| Viatris Specialty LLC | $14.37 | 2025 | Yupelri |
| Eisai INC. | $11.97 | 2021 | |
| Nabriva Therapeutics, Plc | $11.08 | 2021 | |
| Genentech USA, INC. | $4.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wyatt Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.